About CorVista Health
CorVista Health is a digital health company that has developed the CorVista System, an innovative, non-invasive point-of-care diagnostic platform designed to rapidly detect cardiovascular disease. Operating on a medical-device-as-a-service model, the system utilizes a handheld device to capture naturally emitted cardiac and hemodynamic signals from a patient at rest. These physiological measurements are securely transmitted to a cloud-based database where proprietary, machine-learned algorithms analyze the data and deliver a clinical summary within minutes.
For physicians, this technology offers a front-line diagnostic tool to rule out significant coronary artery disease (CAD) with a high negative predictive value, as well as to identify pulmonary hypertension (PH) and signs of heart failure. Because the test is performed at rest and requires no fasting, radiation, contrast agents, or cardiac stress, it significantly mitigates patient risk and streamlines the diagnostic pathway. The rapid turnaround of results during the same clinical visit enables immediate, informed decision-making regarding patient care and downstream testing.
By eliminating the need for capital-intensive imaging equipment or specialized infrastructure, the CorVista System is particularly suited for low-resource, rural, and underserved clinical settings. This allows primary care physicians and clinics to extend high-quality cardiovascular assessments to populations that otherwise face barriers to specialist care, thereby advancing health equity and improving early disease detection.
Focus Areas
Business Intelligence
| Key Investors | Pebble Accelerator, Ambix Ventures, Arrize Capital, MedVenture Partners, Ambix Life Science Fund I L.P., Peter N. Townshend, G Ventures |
| Partnerships | Mayo Clinic, Advanced Telecommunications Solutions and Services (ATSS) |
| Acquisitions | unknown |
| Technology | Cloud-based AI/ML algorithms, portable hardware for physiological signal collection |
| FDA Clearances | 2 cleared products (estimated) |
What Physicians Need to Know
For physicians, CorVista Health's system offers a significant advantage by providing rapid, non-invasive, point-of-care diagnostics for cardiovascular conditions like CAD and PH. This can lead to quicker diagnoses and treatment decisions, reducing the need for immediate referrals to specialists or invasive procedures. The system's ease of use and portability make it suitable for various clinical settings, including local physician offices, clinics, and even underserved areas, improving patient access to advanced cardiac care. The detailed diagnostic reports, available in a secure web portal, aid in guiding therapy and improving patient outcomes. The new AMA Category III CPTu00ae code (1104T, effective Jan. 1, 2027) also supports reporting for the use of the CorVista System, which may facilitate reimbursement pathways.
The CorVista System is designed as a platform device with a base system that allows for integration with indication-specific 'Add-Ons' for various diseases. It utilizes cloud-based services for secure storage of patient data and application of its FDA-validated algorithms, with diagnostic reports automatically pushed back to the doctor's office. The system's internet-deployable nature, requiring only a Wi-Fi or cellular signal, highlights its inherent connectivity and potential for seamless integration into existing digital health infrastructures.
Products by CorVista Health
What the Web Says
CorVista Health is generally viewed as an innovative company in the healthcare technology space, particularly for its CorVista System which offers rapid cardiac imaging and diagnostic support. Employer reviews suggest a positive work environment with opportunities for growth, though some common startup challenges like rapid change and high expectations are present. Product reviews highlight the speed and efficiency of their imaging system as a significant advantage for patient care.
Overall: PositiveStrengths
- Innovative technology for rapid cardiac imaging (CorVista System)
- Potential for quicker diagnosis and improved patient outcomes
- Positive work culture and supportive colleagues reported by employees
- Opportunities for professional growth and learning within the company
- Strong leadership and clear company vision
- Efficient and user-friendly product interface
Limitations
- As a growing company, some employees note rapid changes in direction or roles
- High expectations and demanding work environment at times
- Limited public product reviews available on major platforms like G2/Capterra
- Specific pricing or implementation challenges not widely discussed publicly
- Potential for long hours due to startup nature
- Reliance on new technology may require adaptation for some users
Based on reviews from: Glassdoor, Reddit, Healthcare IT News (articles/mentions), Company website (for product information and claims), Industry publications and press releases
Last updated: 2026-07-11
Videos
News, demos, and interviews about CorVista Health.
Videos load interactively. If none appear, search YouTube for CorVista Health →
Press & Coverage
Frequently Asked Questions
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]